Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott Labs: 3 Reasons to Be Long-Term Bullish
Seeking Alpha
Wednesday, April 6, 2011 - 8:15am
tags:
Abbott Laboratories
On Novartis's Patent Dispute in India
Seeking Alpha
Wednesday, April 6, 2011 - 8:14am
tags:
India, patents, Gleevec, Novartis
10 promising late-stage cancer drugs
Fierce Biotech
Tuesday, April 5, 2011 - 10:47pm
tags:
cancer, Carfilzomib, crizotinib, vismodegib, Oncovex, PLX4032, Ponatinib, SGN-35, tivozanib, T-DM1, cabozantinib, ONYX Pharmaceuticals, Pfizer, Genentech, Curis, Amgen, Plexxikon, Seattle Genetics, Ariad Pharmaceuticals, Aveo Pharmaceutical, Exelixis, Roche
The Incredible Shrinking Eye Care Sector
Seeking Alpha
Tuesday, April 5, 2011 - 10:40pm
tags:
eye health, Allergan, Alcon, Essilor, Inspire, Ista, JNJ, Merck, Novartis, Pfizer
Apthera Acquisition Puts RXi Pharmaceuticals in New League
Seeking Alpha
Tuesday, April 5, 2011 - 10:15pm
tags:
Apthera, RXi Pharmaceuticals
Bankers expect more Japanese-led M&A in pharma
Fierce Pharma
Tuesday, April 5, 2011 - 9:58pm
tags:
M&A, Japan
Seattle Genetics shares rise in heavy trading
Bizjournals.com
Tuesday, April 5, 2011 - 9:55pm
tags:
Seattle Genetics, antibody-drug conjugate
Cephelon rejects Valeant takeover offer
Marketwatch
Tuesday, April 5, 2011 - 9:11pm
tags:
hostile bid, Valeant Pharmaceuticals, M&A, Cephalon
Cubist Soars on Settlement
Minyanville
Tuesday, April 5, 2011 - 9:10pm
tags:
Cubist Pharmaceuticals, Teva Pharmaceuticals, settlements, Cubicin
Optimer Wins FDA Panel’s Backing for Antibiotic Fidaxomicin
Bloomberg
Tuesday, April 5, 2011 - 9:06pm
tags:
Optimer, FDA, antibiotics, fidaxomicin, advisory panels
Genzyme, Isis Say Mipomersen Cut LDL-C in Two Studies
Bloomberg
Tuesday, April 5, 2011 - 10:49am
tags:
Isis Pharmaceuticals, Genzyme, mipomersen, LDL-C
Ahead of the Bell: Nasdaq halts Optimer trading
Yahoo/AP
Tuesday, April 5, 2011 - 10:43am
tags:
Optimer, antibiotics, fidaxomicin
Neurocrine Tardive drug meets midstage study goals
Yahoo/AP
Tuesday, April 5, 2011 - 10:38am
tags:
Tardive, Neurocrine
Merck to acquire Inspire Pharma for $430 million
Reuters
Tuesday, April 5, 2011 - 10:28am
tags:
Inspire, Merck, M&A
J&J, Bayer’s Xarelto Curbs Clots, Raises Bleeding Risk in Clinical Study
Bloomberg
Tuesday, April 5, 2011 - 10:24am
tags:
JNJ, Bayer, Xarelto
Blockbuster antibodies face a unique set of challenges
Fierce Biotech
Tuesday, April 5, 2011 - 9:13am
tags:
monoclonal antibodies, antibodies
4 Biotech Companies That Could Be Buyout Targets
Seeking Alpha
Tuesday, April 5, 2011 - 9:07am
tags:
Athersys, Biomarin, Celgene, Amgen
Gilead Sciences Raises Price Of Top Selling Products
Morningstar
Tuesday, April 5, 2011 - 8:42am
tags:
Gilead Sciences, drug pricing, HIV
Optimer Pharma: FDA Panel Live Blog
TheStreet.com
Tuesday, April 5, 2011 - 8:36am
tags:
FDA, advisory panels, Optimer, antibiotics, fidaxomicin
Valeant Pressures Cephalon for Faster Decision, Goes Hostile With $5.7B Bid
Seeking Alpha
Tuesday, April 5, 2011 - 8:34am
tags:
hostile bid, Cephalon, Valeant Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.